Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefania Merighi

Showing results (51-60 of 105) with videos related to

Pageof 11
Sort By:
Neuropharmacology|February 4, 2014
TRR469, a potent A(1) adenosine receptor allosteric modulator, exhibits anti-nociceptive properties in acute and neuropathic pain models in miceFabrizio Vincenzi, Martina Targa, Romeo Romagnoli, et al.
Biochemical Pharmacology|October 16, 2007
Thermodynamics of A2B adenosine receptor binding discriminates agonistic from antagonistic behaviourStefania Gessi, Eleonora Fogli, Valeria Sacchetto, et al.
Pharmacology & Therapeutics|October 11, 2003
A glance at adenosine receptors: novel target for antitumor therapyStefania Merighi, Prisco Mirandola, Katia Varani, et al.
Neoplasia (New York, N.Y.)|October 2, 2009
A(2B) and A(3) adenosine receptors modulate vascular endothelial growth factor and interleukin-8 expression in human melanoma cells treated with etoposide and doxorubicinStefania Merighi, Carolina Simioni, Stefania Gessi, et al.
Pharmaceutics|October 28, 2023
Strategies for Drug Delivery into the Brain: A Review on Adenosine Receptors Modulation for Central Nervous System Diseases TherapyMercedes Fernandez, Manuela Nigro, Alessia Travagli, et al.
Current Medicinal Chemistry|June 25, 2005
Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine ligands, new tools to characterize A3 adenosine receptors in human tumor cell linesPier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Romeo Romagnoli, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 17, 2009
Adenosine modulates HIF-1{alpha}, VEGF, IL-8, and foam cell formation in a human model of hypoxic foam cellsStefania Gessi, Eleonora Fogli, Valeria Sacchetto, et al.
Journal of Cellular Physiology|September 18, 2016
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial CellsFabrizio Vincenzi, Annalisa Ravani, Silvia Pasquini, et al.
Plos One|July 5, 2012
The anti-tumor effect of A3 adenosine receptors is potentiated by pulsed electromagnetic fields in cultured neural cancer cellsFabrizio Vincenzi, Martina Targa, Carmen Corciulo, et al.
Neoplasia (New York, N.Y.)|October 26, 2005
A3 adenosine receptors modulate hypoxia-inducible factor-1alpha expression in human A375 melanoma cellsStefania Merighi, Annalisa Benini, Prisco Mirandola, et al.
Pageof 11

Showing results (51-60 of 105) with videos related to

Sort By:
Pageof 11
Neuropharmacology|February 4, 2014
TRR469, a potent A(1) adenosine receptor allosteric modulator, exhibits anti-nociceptive properties in acute and neuropathic pain models in miceFabrizio Vincenzi, Martina Targa, Romeo Romagnoli, et al.
Biochemical Pharmacology|October 16, 2007
Thermodynamics of A2B adenosine receptor binding discriminates agonistic from antagonistic behaviourStefania Gessi, Eleonora Fogli, Valeria Sacchetto, et al.
Pharmacology & Therapeutics|October 11, 2003
A glance at adenosine receptors: novel target for antitumor therapyStefania Merighi, Prisco Mirandola, Katia Varani, et al.
Neoplasia (New York, N.Y.)|October 2, 2009
A(2B) and A(3) adenosine receptors modulate vascular endothelial growth factor and interleukin-8 expression in human melanoma cells treated with etoposide and doxorubicinStefania Merighi, Carolina Simioni, Stefania Gessi, et al.
Pharmaceutics|October 28, 2023
Strategies for Drug Delivery into the Brain: A Review on Adenosine Receptors Modulation for Central Nervous System Diseases TherapyMercedes Fernandez, Manuela Nigro, Alessia Travagli, et al.
Current Medicinal Chemistry|June 25, 2005
Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine ligands, new tools to characterize A3 adenosine receptors in human tumor cell linesPier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Romeo Romagnoli, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 17, 2009
Adenosine modulates HIF-1{alpha}, VEGF, IL-8, and foam cell formation in a human model of hypoxic foam cellsStefania Gessi, Eleonora Fogli, Valeria Sacchetto, et al.
Journal of Cellular Physiology|September 18, 2016
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial CellsFabrizio Vincenzi, Annalisa Ravani, Silvia Pasquini, et al.
Plos One|July 5, 2012
The anti-tumor effect of A3 adenosine receptors is potentiated by pulsed electromagnetic fields in cultured neural cancer cellsFabrizio Vincenzi, Martina Targa, Carmen Corciulo, et al.
Neoplasia (New York, N.Y.)|October 26, 2005
A3 adenosine receptors modulate hypoxia-inducible factor-1alpha expression in human A375 melanoma cellsStefania Merighi, Annalisa Benini, Prisco Mirandola, et al.
Pageof 11